Detalhe da pesquisa
1.
Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape.
Ann Hematol
; 103(5): 1561-1568, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321229
2.
Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study.
Am J Hematol
; 98(11): 1762-1771, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647134
3.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533127
4.
Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
Cancer Med
; 12(8): 9662-9667, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039261
5.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911708
6.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923264
7.
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.
Front Oncol
; 11: 668261, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33937081
8.
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
Nat Commun
; 11(1): 5938, 2020 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230096
9.
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas.
Blood Adv
; 7(3): 314-316, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35914224
10.
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.
Hemasphere
; 7(3): e852, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36860269